– Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit’s AI-biomarker platform in a wide range of cancer types and clinical practices SEOUL, South Korea, May 10, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer…